From IT Expense to Revenue Driver: How CMS NTAP Activates the Clinical AI Commercial Flywheel
Dr. Dereck Mush, MD, MBAPolicy & Regulation
FDA decisions, legal frameworks, reimbursement rules and government moves that shape what healthtech can build, sell and bill for.
Dr. Dereck Mush, MD, MBA
The Agentic Clinical AI Regulatory Frontier: What ADVOCATE's $62.7M Contract Actually Unlocks
Dr. Dereck Mush, MD, MBA
Breaking the PMA Bottleneck: How FDA's Class II Reclassification Accelerates Precision Oncology
Dr. Dereck Mush, MD, MBA
The Web Summit Dual-Track Playbook: Navigating FDA Clearance and CE-MDR Simultaneously in 2026
Dr. Dereck Mush, MD, MBA
